Cyclosporin neurotoxicity in cardiac transplant recipients.
Open Access
- 1 November 1988
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 51 (11) , 1434-1437
- https://doi.org/10.1136/jnnp.51.11.1434
Abstract
Cyclosporin toxicity may produce a wide range of neurological disorders. We report three patients whose neurological problems developed while taking cyclosporin following cardiac transplantation, but resolved rapidly when the drug was discontinued. In two cases, MRI revealed abnormalities which disappeared with clinical recovery. Blood cyclosporin concentrations were not markedly increased, and it is possible that the neurotoxic effects of cyclosporin are mediated by metabolites, through an effect on the blood-brain barrier.This publication has 12 references indexed in Scilit:
- CYCLOSPORIN METABOLITES AND CENTRAL-NERVOUS-SYSTEM TOXICITYThe Lancet, 1988
- Cerebral blindness and encephalopathy with cyclosporin A toxicityNeurology, 1987
- DISTURBANCE OF BLOOD-BRAIN BARRIER AFTER BONE-MARROW TRANSPLANTATIONThe Lancet, 1985
- SEVERE CENTRAL-NERVOUS-SYSTEM TOXICITY ASSOCIATED WITH CYCLOSPORINThe Lancet, 1985
- CYCLOSPORIN-ASSOCIATED FATAL CONVULSIONSThe Lancet, 1985
- Targeted blood levels of cyclosporine for cardiac transplantationThe Journal of Thoracic and Cardiovascular Surgery, 1984
- Generalised epileptic fits in renal transplant recipients given cyclosporin A.BMJ, 1984
- ASSOCIATION BETWEEN CYCLOSPORIN NEUROTOXICITY AND HYPOMAGNESAEMIAThe Lancet, 1984
- The Infant Seat as Treatment for Gastroesophageal RefluxNew England Journal of Medicine, 1984
- Cyclosporine-Associated Central-Nervous-System Toxicity after Allogeneic Bone-Marrow TransplantationNew England Journal of Medicine, 1984